Summary
Nonobstructive azoospermia (NOA) patients present with high levels of serum FSH.
At the protein level, the aetiology and pathways underlying different subtypes of NOA are unclear. The aim was to evaluate quantitatively differences in proteomic profiles of NOA patients presenting with normal serum FSH and normal testicular volume and high serum FSH and small testicular volume. The study comprised of 14 nonobstructive azoospermic men (N = 4; normal FSH and normal testicular volume and N = 10; high FSH and small testicular volume) and seven normozoospermic men.
Proteomic analysis was done using LC-MS. GSTM3 and PGK2 were less abundant in the normal and high FSH group compared to controls. HSPA4L and HSPA4 were exclusively present in control group whereas HSP90AB1, HSPA1B, HSP90AA1 and HSPA2 were less abundant and exclusive to the normal and high FSH group. We have identified six heat-shock proteins that may have a role in the pathology of NOA. FSH and testicular volume by itself are not good markers of NOA. The inverse association of GSTM3 and PGK2 regulation with FSH levels along with 12 proteins exclusively in NOA groups suggests further evaluation of their predictive potential in a larger cohort of patients.
K E Y W O R D S
FSH, infertility, male, nonobstructive azoospermia, proteomics Even though NOA might indicate impaired spermatogenesis in the entire testis, in 50%-60% of cases, sperm cells can still be produced in some islets (Esteves, 2015) . Therefore, regardless of its type, azoospermia does not imply sterility, as previously assumed (Esteves & Agarwal, 2013) . Invasive procedures such as testicular histology with surgical exploration of the genital tract are the only method for a differential diagnosis of azoospermia. Pregnancies can be achieved using testicular sperm extracted from azoospermic men using assisted reproductive techniques such as intracytoplasmic sperm injection (ICSI) (Vloeberghs et al., 2015) . Testicular sperm extraction (TESE) and testicular sperm aspiration (TESA) are the most common procedures for obtaining sperm cells from azoospermic patients (Rajfer, 2006) . Generally, TESE/TESA is successful in retrieving sperm almost 100% of OA cases (Tournaye et al., 1997) .
In the population of NOA patients, however, the possibility of finding sperm cells is only about 50%, and therefore, random sampling of the testis does not reflect histopathology of NOA accurately, and NOA patients are submitted to multiple testicular biopsies (Tournaye et al., 1997) . The disadvantage of such invasive procedures is that the removal of large fragments of testicular tissue may endanger, in a transient or permanent fashion, the androgen production, possibly leading to severe hypogonadism (Esteves, 2015) . Evaluation of noninvasive pre-operative markers has been suggested to accurately access the histopathological subtypes of NOA and to predict the outcomes of TESE/TESA.
Evaluation of the serum levels of follicle stimulating hormone (FSH) and the testicular volume have been incorporated in clinical routine (Bernie, Ramasamy, & Schlegel, 2013) . Predictive power of these markers is rather poor; however, they continue to be recommended (Tournaye et al., 1996) . Drabovich et al. (2013) compared seminal plasma obtained from NOA, OA and men presenting with normal spermatogenesis and identified ECM1 and TEX 101 as clinical biomarkers for azoospermia. These markers have the potential to distinguish between OA and NOA, improve the confidence of NOA diagnosis, eliminate most of the diagnostic testicular biopsies and TESE/TESA procedures for patients with SCO, and thus facilitate prediction of the outcome of sperm cell retrieval procedures for ART. Furthermore, a simple and promising two-marker decision tree for the noninvasive differential diagnosis of NOA subtypes was proposed that can potentially be incorporated in clinical routine (Drabovich et al., 2013) .
Follicle stimulating hormone is traditionally used as a marker of azoospermia. 25-35% of NOA patients present with high levels of serum FSH (Gudeloglu & Parekattil, 2013) . At the protein level, our understanding of the aetiology and pathways underlying different subtypes of NOA remain unclear. In this study, we used mass spectrometry (MS)-based proteomics to, quantitatively, investigate the seminal plasma of different NOA patients. The aim of this study was to compare proteomic profiles in nonobstructive azoospermia patients with (i) normal serum levels of FSH and normal testicular volume and (ii) high serum levels of FSH and small testicular volume with normozoospermic controls.
| MATERIAL S AND ME THODS

| Study design and subjects
Institutional review board approval was obtained from Cleveland Clinic Research Ethics Committee, and each participant included in this study signed a written informed consent. All patients provided detailed information regarding their medical history, and laboratory tests were performed to access the: (i) testicular volume (of both sides), (ii) hormonal status (testosterone, FSH and LH), (iii) karyotype, and (iv) microdeletion of the azoospermia factor (AZF) region in Y chromosome. Fourteen nonazoospermic patients and seven normozoospermic controls were included in this study.
Patients aged from 20 to 45 years were diagnosed as azoospermic after confirmation of complete absence of sperm by the cytospin and nuclear fast red-picroindigocarmine (NFPIC) staining described below.
| Semen collection and analysis
After liquefaction (20 min at 37°C), seminal parameters (volume, total sperm count, concentration, sperm motility and round cells)
were manually evaluated according to the WHO 5th edition guidelines (WHO, 2010).
| Diagnostic confirmation of azoospermia
After the initial semen analysis, if no sperm cells were observed in a wet smear, samples were centrifuged using the cytospin method as described earlier (Hendin, Patel, Levin, Thomas, & Agarwal, 1998) . The cytopellet was examined with NFPIC stain to assess the presence or absence of sperm cells microscopically in the specimen. A control slide was also prepared to assess stain quality.
Sperm heads stained red, whereas tails stained green. A second sample was examined 2 weeks later to confirm the diagnosis of azoospermia.
| Characterisation of NOA and study groups
Follicle stimulating hormone levels in serum were measured on at least two occasions for each patient. To distinguish between OA and NOA, FSH levels and testicular volume were used, and testicular biopsy results were used where the data were available. The accurate characterisation of NOA was made through the use of the algorithm proposed by. Cocuzza et al. (2013) and based on the results from general physical, andrological and laboratory examination. Accordingly, all 14 azoospermic patients included in this study presented NOA. Schoor et al. found that 96% of men with obstructive azoospermia had an FSH of less than 7.6 mIU/ml or testicular long axis greater than 4.6 cm (Schoor, Elhanbly, Niederberger, & Ross, 2002) . We do not measure testis long axis at our institution but use testicular volume as estimated during physical exam instead. "Normal" testicular volume is difficult to determine, but many studies use greater than 18-20 cm 3 as the cut-off for normal testicular volume (Cocuzza et al., 2013) .
These patients were then divided into two subgroups according to i) levels of FSH ii) testicular volume and iii) abnormal spermatogenesis (evaluated in the testicular biopsy) (Table 1) . Thus, the first subgroup (hereafter high FSH) included 10 NOA patients presenting with high FSH levels (>7.6 mIU/ml; average 24.7 mIU/ml; range 16.7-30.6 mIU/ml) or small testicular volume (<18 cm 3 ; average 10.4 cm 3 ;
range 4-16 cm 3 ) and abnormal spermatogenesis. The second subgroup (hereafter normal FSH) included 4 NOA patients presenting normal FSH levels (6-8.6 mIU/ml; average 5.7 mIU/ml) or normal testicular volume (>18 cm 3 , average 18.7 cm 3 ; range 16-20 cm 3 ) and abnormal spermatogenesis.
| Seminal plasma preparation and SDS-PAGE
After semen analysis, all samples were centrifuged at 4,000 g for 7 min. at 4°C. The clear seminal plasma was supplemented with protease inhibitor cocktail (Roche, Indianapolis, IN) followed by ultracentrifugation at 4°C, 105,000 × g for 45 min. The supernatant was recovered, and protein concentration was determined with the bicinchoninic acid assay (BCA) (Thermo Scientific, Rockford, IL).
Aliquots containing 25 μg of total protein were separated from each pool, mixed with standard sodium dodecyl sulphate (SDS) buffer, boiled and proteins separated using gel electrophoresis (SDS-PAGE).
Briefly, samples were applied in a 12.5% Tris-HCl gel (Bio-Rad, Hercules, CA). Subsequently, the protein-containing gel was placed in a Bio-Rad PowerPac Electrophoresis system (Bio-Rad, Hercules, CA), and electrophoresis was then performed using Tris/Glycine/SDS (TGS buffer) for 35 min at 150V. The short gel was fixed for 30 min in 50% (v/v) ethanol, 10% (v/v) acetic acid solution, washed with water thoroughly and stained with GelCode Blue (Thermo Fisher Scientific, Rockford, IL). The protein bands were excised and cut into five smaller pieces; this procedure was followed by in-gel digestion using standard protocol as proposed by Shevchenko et al. (1996) .
Gel pieces were initially destained by washing with acetonitrile and subjected to reduction with 50 mm DTT (in 100 mm ammonium bicarbonate) and alkylation with 150 mm Iodoacetamide (in 100 mm ammonium bicarbonate). Reduction and alkylation steps were performed at room temperature for 1 hr. The in-gel digestion step was carried out using 5 μl sequencing grade-modified trypsin (10 ng/μl trypsin in 50 mm ammonium bicarbonate) (Promega, Wisconsin, WI).
| LC-MS/MS analysis and protein identification
The LC-MS/MS analysis was performed by coupling a Dionex were accepted if they could be established at >99.0% probability to achieve a false detection rate (FDR) <1.0% and contained at least 2 identified peptides.
| Relative quantification and 203-analysis
The total number of mass spectra that matched peptides to a particular protein (termed Spectral counts) was used to access the regulation of proteins in the complex mixture. Normalisation of spectral counts using the NSAF (normalised spectral abundance factor) (NSAF = SC/ (ΣSC*protein length)) approach was applied prior to relative protein quantification (Zhang, Wen, Washburn, & Florens, 2010; Zybailov, Coleman, Florens, & Washburn, 2005) . Appropriate filters were used to identify differentially expressed proteins (hereafter DEP) that were dependent on the overall regulation of the proteins. Normalised ratios were calculated to access the proteins showing differential regulation, and statistical significance was assessed using two-tailed statistical tests. The NSAF values were used to access the ratios (fold-change) among the three groups (normal FSH/Control, high FSH/Control and normal FSH/high FSH), which were further normalised by log 2 transformation. By comparing all identified proteins between these groups, it was possible to observe the presence of group exclusively identified proteins. These proteins were filtered, and only those presenting spectra collected in three out of three MS runs were considered for further data analysis.
The criteria for classifying DEPs into upregulated or downregulated protein(s) was based on the log-transformed ratios >0 (upregulated) and <0 (downregulated).
| Functional interpretation
Functional interpretation of the results analysis was done using publicly available software packages such as the Gene Ontology 
| RE SULTS
The FSH levels, testicular volume and biopsy findings where available are shown in Table 1 . A total number of 542 individual proteins were detected.
| Label-free quantitation by spectral counting and group comparisons
The relative quantity of proteins was determined by comparing its spectral counts number. The numerical values used in the quantitation correspond to the NSAF. The total spectral counts collected in this study ranged from 15,698 to 20,715, and their distribution according to group can be observed in Figure 1a . Moreover, the spec- 
| Normal FSH vs. control group
The comparison of identified proteins between normal FSH and control groups showed 407 proteins in common ( Figure 1b and Table   S1 ). According to their NSAF ratios (or fold-change), proteins were divided into two categories: downregulated in normal FSH (ratio<0) and upregulated in normal FSH (ratio>0).
Functional interpretation of this differential proteome was done by GO enrichment analysis and revealed that the majority of the upregulated proteins (~33%) belong to the extracellular region ( Figure 2a) . We observed the upregulation of common seminal plasma proteins such as Annexins secreted by the prostate, MUC6
by the bulbourethral glands and Serpins by the seminal vesicles.
Interestingly, although ~41% of downregulated proteins belong to the extracellular region, about 3.5% were annotated as cellular components of sperm cells (Figure 2a) . Thus, the downregulation of ACR, ACRBP, GSTM3, PGK2, TEX101 and TXNDC2 was observed. The proteins PGK2, GSTM3 and TXNDC2 were annotated as part of the sperm flagellum and, therefore, implicated in cellular motility.
While PGK2 and GSTM3 were observed to be 2.5-fold and 1.7-fold downregulated in the normal FSH group, TXNDC2 was exclusively identified in the control group. Likewise, ACR, ACRBP and TEX 101 were exclusively identified in the control group. Some proteins related directly to the testis and epididymis also presented differential regulation in our study. NPC2 and EDDM3B were less abundant in the normal FSH group, respectively. A group of six heat-shock proteins was also observed among the downregulated proteins in the normal FSH group. Detailed information, fold-changes and p-values for each of the aforementioned proteins are found in Table S1 .
| High FSH vs. control group
The comparative results of high FSH and control groups were somewhat similar to the comparison of normal FSH and control. Thus, 407 proteins were commonly observed in both groups (Figure 1c ; Table S2 ). Proteins were divided into two categories: downregulated in high FSH and upregulated in high FSH. The GO enrichment analysis revealed that the majority of the upregulated proteins (~32%) Table   S2 .
| Normal FSH vs. high FSH
The quantitative comparison between normal FSH and high FSH groups showed 425 common proteins ( Figure 2a ; Table S3 ). Among the exclusive identified proteins, 12 followed our criteria (spectra collected in three out of three MS runs). Thus APOE, CALML5, FABP5, PPIA, SERPINB3, TIAM1 and TFF3 were exclusively identified in the high FSH group. Furthermore, APEH, GPC4, MUC5B, MYH and TENM2 were exclusively identified in the normal FSH group. Based on fold-change, proteins were divided into two categories: upregulated in normal FSH and upregulated in high FSH.
Majority of the upregulated proteins in the high FSH group belonged to the extracellular region. Among these, and according to fold-change values, BPIFB2, DSP, BCAM, DSG1 and DSC1 presented greater regulation (Table S3 ). The GO enrichment analysis also revealed that the majority of the upregulated proteins in the normal FSH group belong to the extracellular region. Surprisingly, GSTM3
and PGK2 were upregulated in the normal FSH group (Figure 3b ).
Based on the fold-change, S100A7, S100A8, CFI, DAG1 and LDHC were among the proteins presenting greater fold regulation in the normal FSH group (Table S3) .
| D ISCUSS I ON
| Seminal plasma proteome characterisation of NOA patients
In the present study, we used MS-based proteomics to identify proteins in the seminal plasma from NOA patients, presenting different serum levels of FSH. Interestingly, the majority of proteins showing differential regulation in the normal FSH group also showed differential regulation in the high FSH group, demonstrating that there is no major difference, at the protein level, that could characterise either group.
To date, at least 20 heat-shock proteins (HSPs) have been identified as being related to the spermatogenesis process (Ferlin et al., 2010) . Spermatogenesis is accompanied by the regulation of different HSPs in the testes because different phases (including mitotic proliferation of spermatogonia, meiotic development of spermatocytes, post-meiotic development of spermatids and sperm cells maturation) represent conditions where dramatic transformations and cellular differentiation take place (Meinhardt, Wilhelm, & Seitz, 1999) . In normal cells, HSP 90 comprises about 20% of the total proteins, however, in stressful conditions, its levels can increase up to 10% with a concomitant increase in its activity. It also plays a role in degradation of unfolded proteins and therefore in maintaining protein homeostasis (Khurana & Bhattacharyya, 2015) . In addition to the chaperone activity, HSP 90 plays an important role in regulating transcription factors. HSP90 and its cochaperones are involved in modulating transcription activity by (i) altering the steady state availability of important transcription factors in response to physiological conditions, (ii) modulating activity F I G U R E 3 Venn diagram showing the overlap between the proteins identified in the (a) normal follicle stimulating hormone (FSH) and high FSH groups, (b) Average normalised spectral abundance factor (NSAF) of GSTM3 and PGK2. Bar represents average ± standard deviation calculated for three MS runs, (c) Average NSAF of heat-shock proteins (HSP90AB1, HSPA1B, HSP90AA1, HSPA2, HSPA4L and HSPA4). Bar represents average ± standard deviation calculated for three MS runs of certain epigenetic modifiers such as histone deacetylases or DNA methyltransferases in response to the changing environment and (iii) participating in the removal of histones from the activator region and thereby turning on the gene regulation (Khurana & Bhattacharyya, 2015) .
In our results, a group of four heat-shock proteins (HSP90AB1, HSPA1B, HSP90AA1 and HSPA2) were observed among the downregulated proteins in the NOA groups; moreover, HSPA4L and HSPA4 were exclusively identified in control samples (Figure 3c ).
This fact corroborates with the idea that low levels of HSPs regulation in spermatogonia might lead to a decreased level of protection, which could be involved in low spermatogenic efficiency, discussed earlier (Dix et al., 1996; Meinhardt et al., 1999; Neuer et al., 2000; Werner, Meinhardt, Seitz, & Bergmann, 1997 (Drabovich et al., 2013) . These authors reported that seminal concentrations of TEX101 are capable of differentiating Sertoli cell-only syndrome from other categories of NOA (Drabovich et al., 2013) . Although TEX101 was annotated as a sperm cell protein in our results, immunohistochemistry has confirmed high regulation levels of TEX101 in spermatocytes and spermatids (Drabovich et al., 2013) . The same was observed for GSTM3 and PGK2, and although both proteins were annotated as cellular components of sperm cells, their regulation in the testis has been demonstrated (Comstock, Johnson, Rifenbery, & Henner, 1993; Saribek, Jin, Saigo, Eto, & Abe, 2006) . The differential regulation of these proteins observed in our study indicates that although spermatogenesis may still be going on in the NOA groups, but somehow it is not as intense as in the control group.
Two epididymal proteins, NPC2 and EDDM3B, were also downregulated in the NOA groups, when compared to control. It has been observed that NPC2 is decreased by 40% in seminal plasma from vasectomised men (Robinson, McCarrey, & Simon, 1989) . Additionally, our results suggest that NPC2 is indeed a marker for NOA; however, it does not seem to be effective in distinguishing different NOA samples. Likewise, EDDM3B seems to be a marker of NOA samples, but has no predictive value for normal FSH or high FSH samples.
| Quantitative differences in the proteome of NOA patients presenting high and normal FSH
Interestingly, only ~25% of all identified proteins showed significant differential regulation between NOA groups (Drabovich, Jarvi, & Diamandis, 2011; Lundgren, Hwang, Wu, & Han, 2010) .
Although such similarity may be due to the nature of azoospermia, it is important to emphasise that in the present study we used spectral counting which is a semi-quantitative method, and not remarkably sensitive for small changes, especially in downregulated proteins.
Gene Ontology enrichment analysis was used to examine the origin of the upregulated proteins, and showed that, as expected, the majority of the proteins belong to the extracellular region, regardless of group. Among the extracellular molecules presenting greater regulation (based on spectral counting) in the high FSH group, proteins that play a role in innate immunity, such as BPIFB2, were observed. Similarly, the upregulation of CFI was evidenced in the normal FSH group. Moreover, adhesion molecules and components of intracellular junctions, like DSP, BCAM, DSG1 and DSC1, were found among the proteins that were upregulated in the high FSH group. Additionally, the epithelial S100A7, S100-A8 and DAG1 were found to be upregulated in the normal FSH group. It is known that immune/epithelial cells are constantly secreting and shedding their content into the seminal plasma.
These secretions, however, are dependent on the overall status of the male reproductive tract (i.e., infection and inflammation) and may, therefore, vary from patient to patient (Meijer, Gearry, & Day, 2012) .
The testicular GSTM3 and PGK2 previously observed to be downregulated in NOA samples in contrast to the control group, showed upregulation in the normal FSH group when NOA groups were compared. Although their role in spermatogenesis is not fully elucidated, as discussed before, our results indicate that the testicular regulation of these proteins may be inversely proportional to FSH levels. In this scenario, both proteins may be possible candidates to distinguish NOA patients presenting with different levels of serum FSH. The limitations of our pilot study were (i) small sample size in NOA + normal FSH subjects (ii) We did not have testicular biopsies/ pathological diagnosis for all the patients, laboratory findings of cytospin results where no sperm was seen and FSH levels and testicular volume were used along with testicular biopsies where available (iii) We used the shotgun or label-free proteomic approach in this study and (iv) samples were pooled in the two study groups.
In conclusion, our results from this pilot study suggest that a group of six heat-shock proteins (HSP90AB1, HSPA1B, HSP90AA1, HSPA2, HSPA4L and HSPA4) may be implicated in the pathophysiology of diminished spermatogenesis in NOA patients. We found no major difference in protein regulation that potentially characterises NOA patients presenting low or normal serum levels of FSH. Although the regulation of testicular proteins GSTM3 and PGK2 may be useful in distinguishing low FSH and normal FSH groups, the predictive value of these proteins should be evaluated individually and/or in a larger cohort of patients. The same applies for the 12 proteins identified exclusively in either NOA group. More experimental data is necessary to validate this hypothesis and shed some light on protein networks involved in NOA pathogenesis.
